Literature DB >> 36157284

Phage Therapy in Israel, Past, Present, and Future.

Amit Rimon1,2, Daniel Gelman1,2, Ortal Yerushalmy1, Shunit Coppenhagen-Glazer1, Eyal Katvan3,4, Ran Nir-Paz5, Ronen Hazan1.   

Abstract

The fascinating scientific history of phage therapy has been documented in numerous publications. In this study, however, we focus on an angle of the story that hitherto has remained relatively neglected, namely, phage therapy treatments, and the protagonists that conducted these in Mandatory-Palestine and subsequently the state of Israel, as part of a global trend. We complete the story by describing efforts in the new era of phage therapy in present-day Israel. Copyright 2022, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  Israel phage bank; Mandatory-Palestine; phage history; phage therapy

Year:  2022        PMID: 36157284      PMCID: PMC9436258          DOI: 10.1089/phage.2022.0010

Source DB:  PubMed          Journal:  Phage (New Rochelle)        ISSN: 2641-6530


  57 in total

1.  Genetic regulatory mechanisms in the synthesis of proteins.

Authors:  F JACOB; J MONOD
Journal:  J Mol Biol       Date:  1961-06       Impact factor: 5.469

2.  Phage antibodies: filamentous phage displaying antibody variable domains.

Authors:  J McCafferty; A D Griffiths; G Winter; D J Chiswell
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

3.  Phage therapy experience at the Eliava Institute.

Authors:  M Kutateladze; R Adamia
Journal:  Med Mal Infect       Date:  2008-08-06       Impact factor: 2.152

4.  Improved Technic for Isolation of Dysentery Bacteria from Stools by Formaldehyde Inactivation of Bacteriophage.

Authors:  I J Kligler; E Oleinik; I Czazkes
Journal:  Am J Public Health Nations Health       Date:  1943-06

5.  Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance.

Authors:  Joshua M Borin; Sarit Avrani; Jeffrey E Barrick; Katherine L Petrie; Justin R Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

6.  Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years' experience.

Authors:  Tristan Ferry; Camille Kolenda; Thomas Briot; Sébastien Lustig; Gilles Leboucher; Frédéric Laurent
Journal:  Clin Microbiol Infect       Date:  2021-10-05       Impact factor: 8.067

7.  A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.

Authors:  A Wright; C H Hawkins; E E Anggård; D R Harper
Journal:  Clin Otolaryngol       Date:  2009-08       Impact factor: 2.597

8.  Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.

Authors:  Patrick Jault; Thomas Leclerc; Serge Jennes; Jean Paul Pirnay; Yok-Ai Que; Gregory Resch; Anne Françoise Rousseau; François Ravat; Hervé Carsin; Ronan Le Floch; Jean Vivien Schaal; Charles Soler; Cindy Fevre; Isabelle Arnaud; Laurent Bretaudeau; Jérôme Gabard
Journal:  Lancet Infect Dis       Date:  2018-10-03       Impact factor: 25.071

Review 9.  Phage Therapy in Poland - a Centennial Journey to the First Ethically Approved Treatment Facility in Europe.

Authors:  Maciej Żaczek; Beata Weber-Dąbrowska; Ryszard Międzybrodzki; Marzanna Łusiak-Szelachowska; Andrzej Górski
Journal:  Front Microbiol       Date:  2020-06-05       Impact factor: 5.640

10.  Processing Phage Therapy Requests in a Brussels Military Hospital: Lessons Identified.

Authors:  Sarah Djebara; Christiane Maussen; Daniel De Vos; Maya Merabishvili; Benjamin Damanet; Kim Win Pang; Peggy De Leenheer; Isabella Strachinaru; Patrick Soentjens; Jean-Paul Pirnay
Journal:  Viruses       Date:  2019-03-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.